Achieve Life Sciences, Inc. (ACHV) Financials
ACHV Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 24.3 million | 20.3 million |
2023-06-30 | 28.9 million | 19.2 million |
2023-03-31 | 20.8 million | 20.4 million |
2022-12-31 | 30.0 million | 21.7 million |
ACHV Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -5.2 million | 1.2 million |
2023-06-30 | -6.7 million | 1.2 million |
2023-03-31 | -8.3 million | 1.1 million |
2022-12-31 | -11.1 million | 778000 |
ACHV Net Income
No data available :(
ACHV Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 19.9 million | - | 83000 |
2023-06-30 | 25.1 million | - | 98000 |
2023-03-31 | 16.5 million | - | 112000 |
2022-12-31 | 24.8 million | - | 127000 |
ACHV Shares Outstanding
ACHV Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 15000 | 3.6 million | 3.0 million | - |
2023-06-30 | - | 4.6 million | 3.1 million | - |
2023-03-31 | - | 5.5 million | 3.0 million | - |
2022-12-31 | - | 8.6 million | 2.2 million | - |
ACHV Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 100000 |
2023-06-30 | - | 100000 |
2023-03-31 | - | 58000 |
2022-12-31 | - | 65000 |
ACHV
Price: $4.61
52 week price:
Earnings Per Share: -1.50 USD
P/E Ratio: -2.15
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 92500
Ebitda: -8.6 millionMarket Capitalization: 149.3 million